Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells
- PMID: 2862007
- DOI: 10.1210/endo-117-2-457
Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells
Abstract
The effects of rat hypothalamic GH-releasing factor (GRF) and somatostatin (SRIF) on the release and biosynthesis of rat GH were studied by RIA and quantitative immunoprecipitation using monolayer cultures of rat anterior pituitary cells. In kinetic studies, GRF stimulation of GH release appeared at the first sampling time (20-min incubation) and the effect began to diminish after 2-h incubation with GRF. On the other hand, total (cell plus medium) content of GH significantly increased only after 24-h incubation. To examine the GH-synthesizing effect of GRF more directly, newly synthesized GH labeled by [35S]methionine during incubation with GRF was quantified by immunoprecipitation. The amount of immunoprecipitable GH increased significantly and specifically (compared with the total amount of labeled proteins) also only after 24-h incubation. When GH pools were labeled with [35S]methionine under different schedules, the basal release of newly synthesized GH, which was labeled for 1 h immediately before chase incubation was lower during the first 15 min than stored GH which had been labeled earlier. Basal newly synthesized GH secretion exceeded stored GH secretion after 30 min. GRF stimulated the release of GH from both pools but the stimulation of stored GH was greater. In this system, SRIF suppressed both the basal and stimulated release of GH but did not modify GH biosynthesis under either condition. Newly synthesized GH showed significant degradation during 24-h incubation; neither GRF nor SRIF affected the rate of GH degradation during the same incubation period. These results indicate that 1) GRF stimulates both release and synthesis of GH; 2) these two effects have different kinetics and different sensitivities to SRIF; and 3) GRF stimulates the release of GH from heterogeneous pools disproportionally.
Similar articles
-
Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.Endocrinology. 1988 Sep;123(3):1476-82. doi: 10.1210/endo-123-3-1476. Endocrinology. 1988. PMID: 2900135
-
Human growth hormone (GH)-releasing factor stimulates and somatostatin inhibits the release of rat GH variants.Endocrinology. 1986 Nov;119(5):2097-105. doi: 10.1210/endo-119-5-2097. Endocrinology. 1986. PMID: 2876884
-
Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro.Endocrinology. 1989 Jan;124(1):84-9. doi: 10.1210/endo-124-1-84. Endocrinology. 1989. PMID: 2562828
-
[A hypothalamic hormone-somatostatin--from endocrinology to neurophysiology].Nihon Naibunpi Gakkai Zasshi. 1992 May 20;68(5):507-25. doi: 10.1507/endocrine1927.68.5_507. Nihon Naibunpi Gakkai Zasshi. 1992. PMID: 1353733 Review. Japanese.
-
Growth hormone-releasing factor: a new chapter in neuroendocrinology.Horm Res. 1986;24(2-3):82-90. doi: 10.1159/000180546. Horm Res. 1986. PMID: 2875926 Review.
Cited by
-
Effects of acute administration of growth hormone-releasing hormone (GHRH) and oxytocin on somatotroph cells in sheep: morphometric study and growth hormone (GH) secretion.J Endocrinol Invest. 1995 Jun;18(6):442-9. doi: 10.1007/BF03349743. J Endocrinol Invest. 1995. PMID: 7594239
-
Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1158-65. doi: 10.1152/ajpendo.00054.2011. Epub 2011 Apr 5. Am J Physiol Endocrinol Metab. 2011. PMID: 21467302 Free PMC article. Clinical Trial.
-
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.J Clin Invest. 1997 Feb 15;99(4):789-98. doi: 10.1172/JCI119225. J Clin Invest. 1997. PMID: 9045884 Free PMC article.
-
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0. Pituitary. 2006. PMID: 17036195 Review.
-
Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.J Clin Invest. 1993 Aug;92(2):695-701. doi: 10.1172/JCI116639. J Clin Invest. 1993. PMID: 8349808 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources